With Keytruda, the best-selling drug in the world, facing the end of exclusivity in 2028, BioSpace looks at five drugs that ...

UDENYCA® is a pegfilgrastim biosimilar used to reduce the chance of infection in patients with some tumors. Coherus BioSciences, headquartered in Redwood (NYSE:RWT) City, California, is known for ...

Former SVP and Franchise Head for US Oncology at Jazz Pharmaceuticals, with established track record for leading a portfolio of products spanning ...

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

R-EPOCH is primarily used to treat B-cell non-Hodgkin’s lymphoma. It may also be used alongside other drugs or therapies to treat other types of cancer. Researchers are currently studying its ...

This strategic move involves Coherus divesting its UDENYCA® franchise to Intas, a company incorporated in India. UDENYCA® is a pegfilgrastim biosimilar used to reduce the chance of infection in ...

Greater Effectiveness and Enhanced Safety Profiles of Biosimilars Compared to Their Reference Biologics Increasing Their Adoption Worldwid ...

The ‘Dogs of the Dow’ is a well-known strategy first published in 1991 by Michael Higgins. The plan seeks to maximize the ...

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

Former SVP and Franchise Head for US Oncology at Jazz Pharmaceuticals, with established track record for leading a portfolio ...